A step towards better understanding of pancreatic cancer
(Medical Xpress)—An international team of scientists has observed that the well-studied protein Sirtuin-1, known for helping cells live longer, also appears to play an important role in pancreatic cancer.
Cancer
Feb 05, 2013 |
5 / 5 (1) |
0
Cancer prevalence higher with long duration of diabetes
(HealthDay)—Patients diagnosed with type 2 diabetes have a greater prevalence of cancer with longer diabetes duration and with insulin use, according to a study published online Jan. 8 in Diabetes Care.
Diabetes
Jan 24, 2013 |
not rated yet |
0
How cervical cancer vaccines came to be
(HealthDay)—The cervical cancer vaccine has turned into one of the biggest success stories in the field.
Cancer
Jan 19, 2013 |
5 / 5 (1) |
0
Vital children's cancer drug being underdosed
(Medical Xpress)—A study has found that many patients receiving a potentially life-saving drug for the childhood cancer neuroblastoma are potentially being under-dosed. Every year in the UK approximately 100 children aged ...
Cancer
Jan 18, 2013 |
not rated yet |
0
Discovering a new role for a breast cancer gene
(Medical Xpress)—Researchers at the School of Biosciences have identified an unexpected role for a tumour-associated gene in breast cancer.
Cancer
Jan 18, 2013 |
not rated yet |
0
Ability to metabolize tamoxifen affects breast cancer outcomes, study confirms
For nearly a decade, breast cancer researchers studying the hormone therapy tamoxifen have been divided as to whether genetic differences in a liver enzyme affect the drug's effectiveness and the likelihood breast cancer ...
Cancer
Dec 27, 2012 |
not rated yet |
0
|
The HER2 paradox: HER2-positive stem cells found in HER2-negative breast cancer
A multicenter study led by researchers at UC Davis describes new, paradoxical characteristics of the most common type of breast cancer. The findings shed light on how the disease can evade treatment and could improve diagnosis ...
Cancer
Dec 14, 2012 |
5 / 5 (1) |
0
Rural dwellers less likely to follow cancer screening guidelines
People who reside in rural areas of Utah are less likely to follow colorectal cancer (CRC) screening recommendations than their urban counterparts, according to researchers from Huntsman Cancer Institute (HCI) at the University ...
Cancer
Dec 14, 2012 |
not rated yet |
0
To fight incurable metastatic breast cancer, resistance must be broken
One of the most frustrating truths about cancer is that even when a treatment works, it often doesn't work for long because cancer cells find ways to resist. However, researchers reporting studies done in mice in the December ...
Cancer
Dec 10, 2012 |
not rated yet |
0
|
Obesity and overeating during menopause together promote breast tumor growth and progression
Obese women might be able to eliminate their increased risk for postmenopausal breast cancer by taking measures during perimenopause to prevent weight gain and to therapeutically control the metabolic effects of their obesity, ...
Cancer
Dec 07, 2012 |
not rated yet |
0
Intermountain Healthcare Cancer research provides possible road map for improving healthcare
Given the right equipment, training and skill, an individual surgeon can expect to provide the best possible care on a consistent basis. But how do you get an entire system of surgeons—each with his or her own ideas, backgrounds, ...
Health
Nov 30, 2012 |
not rated yet |
0
Patient's own immune cells may blunt viral therapy for brain cancer
Doctors now use cancer-killing viruses to treat some patients with lethal, fast-growing brain tumors. Clinical trials show that these therapeutic viruses are safe but less effective than expected.
Cancer
Nov 25, 2012 |
3.7 / 5 (3) |
0
|
Optimal dose suggested for dasatinib in ovarian cancer
(HealthDay)—A phase I trial of dasatinib combined with paclitaxel and carboplatin has determined the optimal dose of dasatinib and suggested some efficacy in women with advanced or recurrent ovarian cancer, ...
Cancer
Nov 19, 2012 |
5 / 5 (1) |
0
Heart failure in older breast cancer patients linked to medication
Heart failure is a relatively common complication in older women with breast cancer, but the risk is even higher in those patients treated with adjuvant trastuzumab (Herceptin), Yale School of Medicine researchers report ...
Cardiology
Nov 14, 2012 |
not rated yet |
0
|
PI3-kinase and PARP inhibitor combo may offer new treatment option for triple-neg breast cancers
The simultaneous inhibition of two separate and seemingly unrelated pathways could potentially provide an effective treatment for women with triple-negative breast cancer, according to results of two studies published in ...
Cancer
Nov 12, 2012 |
4 / 5 (2) |
0
